Global Medical Device Market Outlook

As with most industries, the medical device sector was not untouched by the economic crisis, though it has not deterred the industry’s overall growth. Smaller firms, unable to pick up the slack of product development costs previously covered by venture capital investors – now made more cautious by the economic slump – were obliged to curb their activity. Some other small firms, however, chose to merge with larger firms, thereby continuing technological advances without bearing the full burden of the cost. Domestic and international acquisitions and mergers allow a cross-border sharing of resources and knowledge, facilitating continued medical technology innovation despite the tough economic climate.

More evident challenges to the medical device sector include taxes on products in overseas markets as well as incongruous foreign regulatory controls and varying implementation of standards.

Key Players & Regional Markets

The medical device industry covers a wide spectrum of products used in the treatment of patients, including cardiovascular devices, dental equipment, diagnostic devices, medical equipment and supplies, ophthalmic devices, orthopedic devices, respiratory devices and surgical equipment. In the US, medical devices are recognized as such in a book of public pharmacopeial standards, called the United States Pharmacopeia-National Formulary (USP- NF), and its supplements.

Top names in the industry include such medical technology leaders as: Johnson & Johnson, who ranked 40th in the Fortune 500 list for 2011, Abbott Labs (ranked 69), Medtronic (ranked 158), Baxter (ranked 192), Boston Scientific, GE Healthcare Technologies, Becton Dickinson, St. Jude, Stryker Corporation and Beckman Coulter.

Regionally speaking, the US is the leading competitor, holding in excess of 40% of the world medical device market, reports Exvere private investment bank. The US is not only an important player in manufacturing and exporting medical device products but also creates about half of global market demand. It imports lower-technology medical device products, with a notable share coming from China, and tends to export higher-technology device products. While the US may see its stakes in the global market rise in the event of taxes being lowered, practices standardized and standards harmonized, it would also see more staunch foreign competition from countries that, even if they lag behind in innovation or expertise, could compete through the cheaper production of lower-technology medical devices.

Growing domestic production of lower-technology devices not just in China but also in India, Korea, Taiwan and Brazil will help those nations become relative competitors to the US in the future; though the US is set to remain at the top of the higher-technology device market for some time. In fact, the US market is forecast to climb to $ 140 billion in 2013, over double its worth of $ 60 billion just a decade earlier, as indicated by the preliminary results of a Washington State biomedical device study.

While demand for medical devices in developed regions such as Japan, Canada, the EU and the US remains steady with annual growth rates of between 3% and 5%, developing regions are to prove lucrative for US exports, with demand in countries such as India and China showing more than twice the rate of developed countries. China’s sizeable population and healthy economic growth make it an increasingly promising target market. India equally shows potential as an export market for the US medical device sector due to its ever-more affluent population and strong accompanying private healthcare system.

At the moment Germany and the Netherlands are key competitors to the US for market share in higher-technology medical devices. However, some companies, such as Dutch firm Philips Electronics, are not completely independent players in so far as a good deal of their production is carried out in the US.

Medical Device Product Life Cycle

To enter the marketplace, medical devices must comply with pre-defined product life cycle parameters intended to maximize patient safety and ensure the highest quality standards. The product life cycle can be divided into three main phases. The first phase, or early product life cycle, consists of a product concept with its relevant market strategy and financing. The second phase, or the middle product life cycle, involves manufacturing and validation through clinical trials along with packaging and labeling. Lastly, the late product life cycle phase consists of not only the market launch of the medical device but also market analysis that subsequently impacts on successive generations of the product.

Professional Certification

The Medical Device Body of Knowledge, created by the World Medical Device Organization, is an accrediting body that provides online multimedia medical device training. It offers three levels of qualification:

Certified Medical Device Associate (CMDA) – A basic level of knowledge that covers legislation, medical directives, assessment, classification, standards and the role of notified bodies.
Certified Medical Device Professional (CMDP) – This intermediate accreditation teaches the latest standards as applicable in the product life cycle. This course offers training in diverse aspects of medical device knowledge, including project management, worldwide device regulatory systems, clinical investigation submission, and clinical project financing and reporting.
Master Medical Device Professional (MMDP) – This qualification facilitates a more in-depth understanding of regulatory systems and strategies, and also involves training in ethics, reviewing clinical research, post-market assessment, traceability and product recall.

Regulatory Bodies

Australia, Japan, the US, Canada and the EU are the five founding members of the Global Harmonization Task Force (GHTF), a body that seeks to maintain regulatory control over medical devices in a cohesive manner across global markets. The organization has three broad phases of regulatory control for medical devices, which are divided into premarket, placing-on market and post-market frames. Though different regions differ in the specifics of regulatory control, the first two phases involve risk management, licensing and registration while the post-market surveillance phase includes recording distribution, recall procedures and processing complaints.

The GHTF aims to coordinate regulatory efforts, aid technological growth and encourage trade by producing documentation that provides coherent guidelines for its members. The documents are made by GHTF study groups and are split into four areas of expertise: comparison of worldwide medical device regulatory systems, post-market analysis, study of already operational quality system stipulations, and lastly a study group that puts forth principles by which to review medical devices.

The Medical Device Manufacturers Association, a Washington DC-based national trade association, seeks to streamline policy decisions related to the medical device sector through cooperation with the US Congress, the Food and Drug Administration (FDA) and US healthcare payer the Centers for Medicare and Medicaid (CMS).

The FDA Center for Devices and Radiological Health (US FDA/CDRH) is also involved in the regulatory control of medical device products. This body aims to record adverse events of medical devices on the market. One of its initiatives proposes the establishment of a database that would allow easy access to information on US FDA-approved medical devices.

Moving forward, one of the most important tasks for bodies of regulatory control is to set medical device standards applicable in all countries to harmonize and facilitate global trade and promote patient safety.

Market Outlook

Medical device market research shows that the industry is likely to continue going from strength to strength, with the US keeping its top spot for the foreseeable future. The US remains a leader thanks to cutting edge technological innovation and demand from growing markets such as India and China. The industry as a whole is growing largely because of an ageing global population and climbing societal risk factors. In particular, diet-related chronic diseases, such as cardiovascular disease and diabetes, continue to create demand for medical healthcare services.

Equally, the need for medical devices continues to climb, with life expectancy jumping nearly 20 years over the past 50 years. In fact, worldwide demographics are increasingly shifting towards older populations: between 2000 and 2050, populations in developed regions will see those aged over 60 grow from less than 20% to 34%, while the proportion of children aged under 15 is set to decline by 2% from 18%. According to a United Nations report on ageing, by the 2050s, life expectancy at birth will reach 80 years for almost 60% of the global female population. This ageing population, combined with lifestyle-related disease, is the medical device industry’s assurance of increasing market demand.

Source: www.reportlinker.com

David Winer …..

Global Long-term Evolution Test Equipment Industry 2015 : Market Trends and Forecasts by Acute Market Reports

Product Synopsis

2015 Global Long-term Evolution Test Equipment Industry Report is a professional and in-depth research report on the world’s major regional market conditions of the Long-term Evolution Test Equipment industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

The report firstly introduced the Long-term Evolution Test Equipment basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Browse Full Report with Toc: http://www.acutemarketreports.com/report/long-term-evolution-test-equipment-market

The report includes six parts, dealing with:

1.) Basic information

2.) The Asia Long-term Evolution Test Equipment industry

3.) The North American Long-term Evolution Test Equipment industry

4.) The European Long-term Evolution Test Equipment industry

5.) Market entry and investment feasibility

6.) The report conclusion

Part I Long-term Evolution Test Equipment Industry Overview

Chapter One Long-term Evolution Test Equipment Industry Overview

1.1 Long-term Evolution Test Equipment Definition

1.2 Long-term Evolution Test Equipment Classification Analysis

1.2.1 Long-term Evolution Test Equipment Main Classification Analysis

1.2.2 Long-term Evolution Test Equipment Main Classification Share Analysis

1.3 Long-term Evolution Test Equipment Application Analysis

1.3.1 Long-term Evolution Test Equipment Main Application Analysis

1.3.2 Long-term Evolution Test Equipment Main Application Share Analysis

1.4 Long-term Evolution Test Equipment Industry Chain Structure Analysis

1.5 Long-term Evolution Test Equipment Industry Development Overview

Browse here for all category Reports: http://www.acutemarketreports.com/category/nutraceuticals-market

Chapter Two Long-term Evolution Test Equipment Up and Down Stream Industry Analysis

2.1 Upstream Raw Materials Analysis

2.1.1 Upstream Raw Materials Price Analysis

2.1.2 Upstream Raw Materials Market Analysis

2.1.3 Upstream Raw Materials Market Trend

2.2 Down Stream Market Analysis

2.1.1 Down Stream Market Analysis

2.2.2 Down Stream Demand Analysis

2.2.3 Down Stream Market Trend Analysis

Request Free Sample: http://www.acutemarketreports.com/request-free-sample/11718

About Us:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

CONTACT US:

Chris Paul
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email: [email protected]
Website: http://www.acutemarketreports.com/

Related Evolution Articles

Global Animal Healthcare Market is expected to reach USD 41,929.1 million by 2019 : TMR

This market research report provides a comprehensive overview of the global animal healthcare market in terms of demand patterns, ongoing trends, market size, and future market forecasts. The report discusses the ongoing trends in the animal healthcare market, which have a direct impact on crucial market growth factors such as plans for investment, growth strategies, and innovation.

Browse The Market Research Report of Animal Healthcare Market :
http://www.transparencymarketresearch.com/animal-healthcare-industry.html

The information and data compiled in this research report are based on primary and secondary sources of information and also includes vital inputs from industry experts and professionals. On the basis of tabular and graphical representations presented in this market study, one can clearly understand the growth path taken by the global animal healthcare market over the past couple of years.

The historical and present-day market data also enables us to analyze the market in terms of production capacities and resource utilization. This in turn throws light on demand and supply patterns. The report provides, with the help of qualitative and quantitative facts, a detailed account of the growing significance of animal health and the subsequent impact of various end-use segments on the global animal healthcare market.

Get Free Sample Report :
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2446

This report identifies the key participants in the global animal healthcare market and discusses each company in detail, covering information such as business strategies, recent developments, financial performance, product segments, strategic developments, and SWOT analysis.

Overview of the global animal healthcare market

According to this report, rising incidence of diseases in animals and their subsequent carry-over to human beings owing to consumption of animal products and animal companionship is the main factor that is contributing to the growth of the overall animal healthcare market. Surging global demand for milk and meat and growing population of dietary and companion animals are the other factors which drive the animal healthcare market.

Browse Press Release of Animal Healthcare Market :
http://www.transparencymarketresearch.com/pressrelease/animal-healthcare-industry.htm

Rising consumption of meat can be attributed to high income levels, changing lifestyle patterns, and a high population growth rate. The growing trend of pet adoption also fuels the demand for animal healthcare products.

The research report segments the global animal healthcare market on the basis of animal type, product, and region. On the basis of animal type, the animal healthcare market is classified into production animals and companion animals.

Based on product type, this market is segmented into vaccines, feed additives, and pharmaceuticals. Owing to a rapidly growing animal population, the segment of feed additives holds the highest share within the product segmentation of the animal healthcare market.

Browse All Consumer Goods Market Research Reports @
http://www.transparencymarketresearch.com/consumer-goods-market-reports-7.html

The segment of vaccines and pharmaceuticals is expected to expand in the forthcoming years owing to high focus on animal immunization and high incidence of animal diseases. Geographically, the global animal healthcare market is led by North America.

Companies mentioned in the research report

This research report identifies and profiles the following companies in the global animal healthcare market: Vetoquinol, Elanco Products Company, Boehringer Ingelheim Gmbh, Ceva Sante Animale, Virbac SA, Novartis Animal Health Inc., Bayer AG, Merial Ltd., Merck & Co. Inc., and Zoetis Inc.

Major geographies analyzed under this research report are:
Europe
North America
Asia-Pacific
Rest of the World

This report gives you access to decisive data such as:
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for the coming years

Key highlights of this report
Overview of key market forces propelling and restraining market growth
Up-to-date analyses of market trends and technological improvements
Pin-point analyses of market competition dynamics to offer you a competitive edge
An analysis of strategies of major competitors
An array of graphics and SWOT analysis of major industry segments
Detailed analyses of industry trends
A well-defined technological growth map with an impact-analysis
Offers a clear understanding of the competitive landscape and key product segments

About Us :

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

More Animal Articles